Cyprus Employee Share Options and ESOPs: The New 8% Flat Tax (2026) for Startups and Scale-Ups

What is the new 8% flat tax on Cyprus employee share options?

The new 8% flat tax is a preferential Cyprus personal income tax rate that applies to the benefit an employee receives from an approved share option or share-incentive scheme, effective 1 January 2026. Instead of adding the option gain to your salary and taxing it at progressive rates that climb to 35%, the qualifying benefit is carved out and taxed once, at 8%, subject to statutory caps.

The measure is part of the wider Cyprus tax reform 2026, designed to let startups and technology scale-ups compete for talent using equity rather than cash. For a full picture of how personal and corporate rates fit together, see our overview of taxes in Cyprus.

Which benefits and instruments qualify (options, share-acquisition rights, ESOPs)

Qualifying benefits are those arising from an approved employer incentive scheme that grants employees a right to acquire shares, principally classic share options and broader employee share ownership plans (ESOPs). The common feature is that the employee is given the right, under written plan rules, to acquire shares of the employer or its parent company on defined terms.

The regime is built around genuine rights to acquire shares by exercise, so classic share options and ESOP acquisition rights sit squarely within it. Cash-settled arrangements such as phantom shares and share appreciation rights, and nil or low-cost restricted stock units (RSUs), sit less comfortably, because the 50% price floor is drafted by reference to an exercise price that does not map cleanly onto a nil-cost RSU. The Cyprus Tax Department has signalled that further guidance on how time-vested RSUs and cash-settled schemes are treated will follow, so RSU-heavy plans should be structured, and confirmed with the Commissioner, against the approved-plan conditions before any grant.

How the 8% compares to progressive rates up to 35%

The 8% flat rate is a material saving against the progressive Cyprus personal income tax bands, where employment income is taxed at rates rising to 35% on the top slice. The table below shows the headline difference on the same qualifying option benefit.

For a founder or senior hire on a large equity award, the difference between an 8% charge and a 35% marginal charge on the same benefit is the difference that makes equity compensation viable in Cyprus.

When the regime takes effect and the legal basis

The regime takes effect from 1 January 2026. The Cyprus House of Representatives approved the tax reform package on 22 December 2025, and the legislation was published in the Government Gazette of the Republic of Cyprus on 31 December 2025. The 8% treatment sits within the amended Cyprus Income Tax Law.

Technically, the 8% treatment is introduced by Article 20D of the Cyprus Income Tax Law (Law 118(I)/2002, as amended by the December 2025 reform package), the provision KPMG identifies in its analysis of the reform as establishing the preferential regime for approved share-incentive schemes granted to employees and directors.

What makes a share scheme an "approved" plan under the 2026 rules?

An approved plan is one that the Commissioner of Taxation (the Cyprus Tax Department) has sanctioned before options are granted and that satisfies five cumulative conditions. If any condition fails, the benefit falls back to ordinary progressive taxation. The five conditions are set out below and then explained in turn.

• Pre-approval by the Commissioner of Taxation before options are granted.
• A minimum three-year vesting period.
• Non-transferability of the option before the vesting date.
• An exercise or acquisition price of at least 50% of the grant-date fair market value.
• Shares issued by the employer or its parent company.

Pre-approval by the Commissioner of Taxation before options are granted

Pre-approval is the gateway condition: the employer must obtain the Commissioner of Taxation's approval of the plan rules before any options are granted to employees. This sequencing is deliberate, because it prevents businesses from designing a scheme after the fact and then claiming the concessionary rate. Approval attaches to the plan, not to individual grants, so a single approved plan can cover successive cohorts of employees.

Minimum three-year vesting period

The plan must impose a minimum vesting period of three years before the employee can exercise. The three-year lock aligns the incentive with genuine retention and long-term value creation rather than short-term cash extraction. The law fixes the minimum period at three years; the precise statutory start point is expected to be settled in Tax Department guidance, so a prudent plan states expressly that vesting runs for at least three years from the date of grant.

Non-transferability before the vesting date

The option must be non-transferable before the vesting date, meaning the employee cannot sell, assign or otherwise dispose of the right during the vesting window. Non-transferability reinforces that the benefit rewards the individual employee's continued service, and it stops options being traded as freestanding financial instruments before they vest.

Exercise/acquisition price at least 50% of fair market value

The price the employee pays to acquire the shares must be at least 50% of the fair market value of the shares at the grant date. This floor ensures the employee makes a real economic commitment and that the scheme is a genuine incentive rather than a disguised gift of fully valued shares. Valuation of unlisted shares is therefore central, and the grant-date valuation should be documented and defensible.

Shares must be issued by the employer or its parent

The shares acquired under the plan must be shares of the employer company or its parent. This anchors the benefit to the corporate group the employee actually works for and prevents unrelated third-party shares being routed through the scheme. Group structures using a Cyprus parent are common here, and our note on the Cyprus holding company structure explains how a parent can sit above trading subsidiaries.

How do the caps on the 8% rate work?

The 8% rate is not unlimited: it is subject to an annual cap and a separate lifetime cap, and any benefit above either cap is taxed at ordinary progressive rates. The two caps operate together, so a large award can be part-taxed at 8% and part-taxed at up to 35% in the same year.

The annual cap: twice your annual remuneration per year

In any given tax year, the 8% rate applies to qualifying share option income up to twice the employee's annual remuneration from the plan issuer. So an employee whose annual remuneration is EUR 120,000 can shelter up to EUR 240,000 of option benefit at 8% in that year. For this purpose, annual remuneration is read broadly as the employee's total annual remuneration from the plan issuer rather than base salary alone, with the exact treatment of variable components such as bonuses expected to be confirmed in Tax Department guidance.

The lifetime cap: EUR 1,000,000 per person over ten years

Across all approved plans, there is an overall lifetime ceiling of EUR 1,000,000 of qualifying share option income per individual, measured over a ten-year period. Once cumulative qualifying benefit reaches EUR 1,000,000 within that window, the 8% rate is exhausted for that person. This ceiling is measured over a rolling ten-year period per individual and applies cumulatively across all of that person's approved plans.

What happens to income above the caps

Any option benefit that exceeds either the annual 2x-remuneration cap or the EUR 1,000,000 lifetime cap is taxed under the normal progressive personal income tax rules, at rates up to 35%. In practice this means large single-year exercises should be modelled and, where possible, staged across tax years so that more of the benefit lands inside the annual cap.

Worked example. An employee earns EUR 100,000 in annual remuneration and exercises options in 2027 with a benefit of EUR 260,000. The annual cap is 2 x EUR 100,000 = EUR 200,000, taxed at 8% (EUR 16,000). The remaining EUR 60,000 is taxed at progressive rates. The EUR 200,000 also counts toward the EUR 1,000,000 lifetime ceiling, leaving EUR 800,000 of headroom for future years.

When is the tax triggered and how is the benefit calculated?

The tax is triggered on exercise of the option, and the taxable benefit is the market value of the shares at the moment of exercise minus the price the employee actually paid. Grant and vesting are not taxable events in themselves; the charge crystallises only when the employee exercises and acquires the shares.

Exercise as the taxable event

Exercise is the single taxable event under the regime. The employee is not taxed when the option is granted, nor when it vests, but when the option is exercised and shares are acquired. This deferral is favourable, because no tax falls due while the employee simply holds an unexercised (and possibly worthless) option.

Market value at exercise minus the price paid

The benefit equals the market value of the shares at exercise less the exercise price paid. For a listed company the market value is the quoted price; for an unlisted startup it is a valuation of the shares, which is where most disputes arise. The grant-date 50% floor and the exercise-date valuation are separate calculations and both need documenting.

Timing, withholding and reporting obligations

The benefit is reported and taxed for the tax year in which exercise occurs, and the employer will generally have withholding and reporting duties in respect of it. Because the mechanics of payroll withholding on a non-cash benefit can be complex, withholding is operated through the ordinary PAYE payroll mechanism, and the Cyprus Tax Department is expected to issue guidance on both the operational detail and an accepted valuation methodology for unlisted shares. Employers should therefore agree the withholding process and the valuation basis with the Commissioner ahead of the first exercise.

How do you get a plan approved? A step-by-step how-to

To get a plan approved you draft plan rules that meet the five statutory conditions, apply to the Commissioner of Taxation before any grants, support the application with valuations and documentation, and maintain records for the life of the scheme. The four stages below turn the conditions into a practical sequence.

1. Draft the plan rules to satisfy all five conditions (pre-approval, three-year vesting, non-transferability, 50% price floor, employer or parent shares).
2. Apply to the Commissioner of Taxation for approval before granting any options.
3. Assemble supporting documentation, including a grant-date valuation of the shares and the corporate authority to issue them.
4. Keep records of grants, vesting, valuations and exercises for audit.

Drafting the plan rules to meet the five conditions

Drafting is where approval is won or lost, because the plan rules must expressly build in each of the five conditions rather than leave them to practice. The rules should fix the vesting period at a minimum of three years, prohibit transfer before vesting, set the exercise price at no less than 50% of grant-date fair market value, and confirm that the shares are those of the employer or its parent. Setting up the issuing entity correctly is a related step; see our guide on how to open a company in Cyprus.

Applying to the Commissioner of Taxation

The application goes to the Commissioner of Taxation and must precede any grant of options under the plan. The submission should present the plan rules, the corporate structure, the class of shares and the valuation basis, so the Commissioner can confirm the scheme qualifies. Because approval is a precondition of the 8% rate, the timing of the application relative to the intended grant date is critical.

Documentation, valuations and record-keeping

Robust documentation and a defensible valuation are the backbone of an approved plan, since the 50% price floor and the exercise-date benefit both depend on share value. For unlisted shares this means a methodology the Commissioner will accept, kept on file alongside board resolutions, grant letters and a register of grants, vesting and exercises. Good record-keeping is also your first line of defence in any subsequent audit.

Common reasons approval is refused

Approval is most often refused where the plan is designed for related parties, where the vesting or price conditions are not properly built in, or where grants have already been made before approval. Schemes that benefit related parties within the meaning of Article 33 of the Cyprus Income Tax Law (the arm's length provision) are excluded, so plans skewed toward controlling shareholders or their connected persons are vulnerable.

What are the transitional rules for pre-2026 schemes?

Transitional provisions allow certain pre-2026 schemes to migrate into the 8% regime, provided the employer applies to the Commissioner of Taxation by 30 June 2026. The relief targets plans that were already running when the reform took effect, so existing arrangements are not simply shut out.

Plans whose vesting started before 1 January 2026

Plans whose vesting began before 1 January 2026 can be brought within the 8% regime if they otherwise meet the conditions, so a scheme already part-way through its vesting period is not automatically disqualified. The key is that the plan can be aligned with the approved-plan requirements and submitted for approval within the transitional window.

The 30 June 2026 vesting and application deadline

The transitional deadline is 30 June 2026, and it works in two ways: the three-year vesting must not conclude before that date, and the employer must apply to the Commissioner of Taxation for approval by that date. Both limbs must be satisfied, so employers with legacy option plans should diarise 30 June 2026 as a hard cut-off and prepare the application well ahead.

Migrating a legacy plan into the 8% regime

Migrating a legacy plan means reviewing the existing rules against the five conditions, amending them where needed, and filing for approval before 30 June 2026. In our practice, the most common gaps in legacy plans are a vesting period shorter than three years, an exercise price below the 50% floor, or transfer rights that breach the non-transferability condition. Each of these can often be corrected by amendment before the application is filed.

How were option gains taxed before 2026, and what changed?

Before 2026, option gains were treated as an employment benefit-in-kind and taxed at progressive personal income tax rates up to 35%, with no dedicated concession. The 2026 reform replaced that treatment, for approved plans, with the flat 8% rate and the associated caps.

Prior treatment as benefit-in-kind at progressive rates

Under the prior treatment, the benefit from exercising an option was simply added to the employee's taxable employment income and taxed at their marginal rate, up to 35%. There was no separate share-scheme category and no cap-based concession, which made equity awards expensive to deliver relative to cash in a competitive hiring market.

Why Cyprus reformed the regime for startups

Cyprus reformed the regime chiefly to help startups and technology scale-ups attract and retain talent with equity, a point advocated by industry bodies such as TechIsland. Early-stage companies are cash-constrained and rely on options to compete with larger employers, so a punitive tax on exercise blunted a core recruitment tool. The 8% rate restores equity as a workable incentive.

Interaction with the wider 2026 tax reform

The share-option change is one element of a broader 2026 tax reform that also touches corporate tax, personal allowances and other incentives. Read alongside the notional interest deduction and the IP Box regime for tech founders, the option regime forms part of a package aimed at making Cyprus a base for innovation-led businesses.

Who benefits most: founders, employees and scale-ups?

The regime benefits most those who receive meaningful equity in Cyprus companies: startup and scale-up employees paid partly in options, relocating and non-domiciled hires, and directors and key executives. The common thread is a sizeable option benefit that, before 2026, would have been taxed at up to 35%.

Startups and technology scale-ups using equity to hire

Startups and technology scale-ups gain the most, because equity is central to how they compete for talent against better-funded rivals. An approved plan lets a Cyprus scale-up offer options that, on exercise, are taxed at 8% rather than 35%, materially improving the after-tax value of an offer without extra cash cost to the company.

Non-domiciled and relocating employees

Non-domiciled and relocating employees benefit both from the 8% option rate and from Cyprus's wider personal-tax settlement. The 8% applies to the option benefit regardless of domicile, and non-doms additionally remain outside the Special Defence Contribution net on later dividends. See our guide to non-domiciled tax residency status and the 60-day tax residency rule for how relocation fits together.

Directors and key executives

Directors and key executives with large awards benefit from the 8% rate but must watch the caps and the related-party exclusion. Because senior awards are often the largest, the annual 2x-remuneration cap and the EUR 1,000,000 lifetime ceiling bite hardest here, and controlling-shareholder directors risk falling foul of the Article 33 related-party restriction.

How does the 8% regime interact with other Cyprus taxes?

The 8% regime taxes only the option benefit on exercise; what happens afterwards (dividends, later disposal and non-dom reliefs) is governed by the ordinary Cyprus tax rules. Understanding the full lifecycle of the shares matters as much as the exercise charge itself.

Dividends, SDC and GHS after exercise

Once shares are held, dividends are subject to Cyprus's normal rules: non-domiciled individuals are exempt from Special Defence Contribution (SDC) on dividends, but General Healthcare System (GHS/GESY) contributions still apply, subject to the GHS cap. Domiciled individuals, by contrast, pay SDC on dividends. The exercise charge and the dividend charge are separate events.

Capital gains on later disposal of shares

Cyprus does not levy capital gains tax on the disposal of shares, except where the company's value derives from immovable property situated in Cyprus. For most startup and scale-up shares, a later sale therefore falls outside Cyprus capital gains tax, though the position in the country of residence at the time of sale must always be checked.

Interaction with non-dom status and the IP Box

The option regime dovetails with non-dom status and, at the corporate level, with the IP Box regime for tech founders. A founder can combine a low effective corporate rate on qualifying IP income with an 8% personal rate on option benefits and non-dom dividend relief, producing an efficient overall structure when each element is properly documented.

What are the practical pitfalls and compliance risks?

The main pitfalls are trying to structure retroactively, breaching the related-party and arm's length restrictions, and losing valuation disputes on audit. Each can convert an intended 8% charge into a progressive charge of up to 35%, so they should be managed from the outset.

Retroactive structuring does not work

Retroactive structuring does not secure the 8% rate, because the plan must be approved before options are granted. A scheme cannot be reverse-engineered after grants have been made and still qualify, save within the specific transitional window closing on 30 June 2026. Sequencing the approval before the grant is therefore non-negotiable.

Related-party and arm's-length restrictions

Schemes benefiting related parties are excluded, by reference to Article 33 of the Cyprus Income Tax Law, the arm's length provision. Plans concentrated on controlling shareholders or their connected persons risk disqualification, so eligibility rules and allocations should be reviewed against the related-party test before the plan is submitted.

Valuation disputes and audit exposure

Valuation is the most common audit flashpoint, because both the 50% grant-date floor and the exercise-date benefit depend on the value of unlisted shares. A weak or undocumented valuation invites challenge and can unwind the intended tax outcome. A defensible methodology, contemporaneous documentation and consistent record-keeping are the best protection.

How Philippou Law Firm can help

Philippou Law Firm advises founders, HR and finance teams on designing approved share option plans, drafting compliant plan rules, and applying to the Commissioner of Taxation for approval within the 8% regime, including the 30 June 2026 transitional window for legacy schemes. We model the annual and lifetime caps against real exercise scenarios, coordinate valuations for unlisted shares, and align the plan with your wider Cyprus tax position. Contact our tax team to review or approve your scheme before your next grant.

This article is general information, not legal advice. Figures and deadlines reflect the position as at August 2026 and should be confirmed for your circumstances.